The infant mortality rate is the most accessible health statistic of all time. Simply calculated from routinely collected birth and death certificates, the infant mortality rate has been linked a variety of issues, many social, many biologic in nature. The inherent tragedy of infant death and the wide acceptance of populations of infant death as an indicator of social conditions and societal inequity have conveyed to the infant mortality rate a powerful public presence. For more than 200 years, infant mortality rates have been invoked in support of any number of political positions, including those of both candidates during the last set of presidential debates.
Despite its accessibility, few realize, however, that the relationship between infant mortality and societal forces has undergone enormous change over the past several decades. Few recognize that although social inequity remains a central concern, developments in obstetrics and neonatology have altered forever the pathways by which social inequity is expressed as disparate infant outcomes. This discussion explores the nature of this transformation and draws its broader lessons regarding the implications of unprecedented medical innovation in a society increasingly characterized by deepening social stratification.
The Impact of Tertiary Medical Care on Perinatal Outcomes: Rethinking the Pediatric Commitment to Women's Health
The best place to begin to gauge the dynamic character of infant mortality is with the actual distribution of infant deaths in the United States. Approximately two-thirds of all infant deaths occur during the first 28 days of life, making the determinants of mortality during this period of central concern. When one examines this neonatal mortality by gestational age and birth weight, a profound concentration of mortality in the premature and extremely low birth weight categories is striking. For 1995, for example, almost two-thirds of all neonatal mortality in the United States was due to deaths occurring to neonates born at Ͻ26 weeks' gestation.
1,2 An even larger portion of the racial disparity in neonatal mortality was due to premature infants of Ͻ26 weeks' gestation; almost 32% of the disparity occurred in newborns of Ͻ24 weeks' gestation. It is useful to remember that the legal abortion limit is 24 weeks' gestation.
This deep concentration of neonatal and therefore, infant, mortality in extreme prematurity did not always exist. Rather, it reflects the profound impact of perinatal care on patterns of neonatal mortality in the United States. It is not always recognized that what has driven down neonatal mortality in the United States over the past two decades has been dramatic reductions in the mortality rate of high risk infants once born. 3, 4 Although these reductions in birth weight and gestational age-specific mortality have occurred in virtually all birth weight and gestational age groups, the relative improvements have been greatest for neonates with birth weights of Ͼ1000 gm, the group that has traditionally accounted for the vast majority of neonatal deaths in the United States. These improvements in survival associated with advances in perinatal care had the effect of concentrating neonatal mortality into the most premature and very low birth weight newborns. 5 This concentration of mortality into the most premature newborns has altered profoundly the traditional pathways by which social forces are expressed in patterns of infant death. First, because so much of neonatal mortality is now due to extreme prematurity, social factors must increasingly act on events occurring early in pregnancy, or more importantly, before conception. Overwhelmingly, programs attempting to reduce social disparities in infant mortality in the United States have primarily focused on enhancing prenatal services to women once they become pregnant. Most such large-scale programs have had trouble initiating substantial services to high-risk patients before the middle of the second trimester. Given the large portion of neonatal deaths occurring to newborns of Յ25 weeks' gestation, this confined prenatal approach does not provide for a large window of opportunity to prevent extreme prematurity. In addition, most suspected mechanisms of social influence on birth outcomes, including chronic medical conditions, inadequate nutrition, social and occupational stress, and behavioral factors such as smoking, drug, or alcohol use, not only generally predate pregnancy but also almost always require prolonged, continuous intervention. Even the prospect of preventing prematurity by treating low-grade infectious processes may be best served by the identification of cases and the initiation of treatment before conception. 6 -8 Moreover, the provision of contraception and related services to women when they are not pregnant may prevent unwanted pregnancies, which can reduce birth intervals and generate a number of social, economic, psychological, and medical challenges to a woman's health and well being.
To move beyond the tight focus on the prenatal period means that the child health community must address the requirements of women's health regardless of pregnancy status. The recent interest in what has been labeled "preconceptual" care is useful, but it does not include the scope of interventions necessary to significantly improve current levels of prematurity and other adverse birth outcomes. The majority of pregnancies are unplanned and do not generally involve sustained care. Similarly, "interconceptional care" continues to link services to women on the basis of reproductive outcomes and does not address the fact that approximately half of all births occur to women who have never had a prior birth. Although preconceptional and interconceptional care are constructive recommendations, at some point, a more comprehensive commitment to women's health regardless of pregnancy status will be needed.
Does Medical Innovation Diminish or Widen Social Disparities in Outcome?
The introduction of any new, effective, medical intervention always has the dual potential to reduce or widen extant disparities in outcome. Virtually by definition, any intervention deemed effective will have been shown to reduce the absolute incidence, prevalence, or severity of an illness or traumatic event. Indeed, most important innovations are efficacious in improving the health of individuals in all social groups. However, an ability to reduce absolute morbidity or mortality from a given condition says nothing as to how it will affect disparities in the condition in question. For example, analysis of data from the National Maternal and Infant Health Survey suggests that eliminating maternal smoking in pregnancy would be highly beneficial and reduce rates of low birth weight in all social groups; however, the income and racial disparities in low birth weight rates would not change, and might even widen. Indeed, the largely parallel reduction of black and white neonatal mortality rates in the United States over the past 30 years suggests that factors associated with absolute declines may be quite different than factors associated with disparities between these absolute rates; factors that drive rates down may be different than factors that drive them apart.
New interventions are most likely to influence relative differences in health outcomes when two conditions are met: (1) the intervention is highly effective and (2) there are major socially generated barriers affecting access to the intervention in question. Intuitively, interventions wholly without efficacy are not likely to create disparities in outcome even if differences in access exist. However, when interventions are of high efficacy, differences in access to them will dominate the creation of disparities in outcome. When interventions are of low efficacy, differences in the socially generated risk status of populations will determine the scope of disparities in outcome. Poverty and social oppression will always be unjust, but their power to generate disparities in health will always be potentially mediated by medical capacity.
Indeed, in a setting of profound social inequity, the purpose of medical care is to uncouple poverty from its implications for health. Rarely do clinicians have much impact on the income or social position of their patients. Rather, the clinician attempts to use clinical interventions to create equity in outcome despite persistent inequities in social conditions. Even though income inequality has grown over the past decade, wide access to immunization against Haemophilus influenza has, in the United States, created relative equity in H. influenza meningitis. In reality, unlike for immunization, the clinician's capacity to uncouple poverty from its health implications is rarely so complete. However, it is also rarely nonexistent. Almost always, clinical capability is mixed, providing clinicians with some capacity to alter what social risk conveys to health outcomes. Not only is this capacity mixed, it is also intensely dynamic. Amid a revolution in medical knowledge and clinical capacity, the mechanisms of disparity creation must be seen as perpetually in transition. With each announcement of some new, efficacious treatment, the machinery of disparity creation is inevitably, and irrevocably, altered. The announcement, for example, that azidothymidine (AZT) was effective in reducing the vertical transmission of human immunodeficiency virus shifted some significant portion of the disparity in pediatric human immunodeficiency virus infection away from "risky" parental behaviors to differentials in the provision of AZT to pregnant women in need. Similarly, the development of triple therapy has made access to these complex pharmaceutical regimens a contributor to current disparities in AIDS.
The "Back to Sleep" campaign, the effort to reduce the incidence of sudden infant death syndrome through changes in infant sleep position, has been associated with large reductions in sudden infant death syndrome mortality. It has been one of the great success stories in pediatrics over the past few years. However, it is quite possible that the "Back to Sleep" initiative has exacerbated social differences in sudden infant death syndrome mortality. Although mortality data will have to be examined over the next few years, there is strong evidence that the impact of the campaign has been far more dramatic in altering infant sleep position in wealthier families compared with their poor counterparts. 9 Functional differences in access to this new, effective, and highly beneficial innovation may have become a primary generator of social differences in sudden infant death syndrome mortality.
A similar effect may be occurring in the social distribution of serious congenital anomalies. The rapid development of prenatal diagnostic techniques has altered the prevalence of severe congenital anomalies at birth. However, functional access to these new techniques (not to mention access to abortions in some areas) appears to be socially skewed to wealthier populations. In such a setting, it would not be surprising to find the emergence of broad social disparities in neonatal congenital anomaly mortality, one of the few arenas of pediatric mortality that has traditionally not been characterized by large social differences.
The efficacy of the intervention itself, however, says nothing as to the direction of its effect on disparities. Although fertility assistance therapy has proven to be of great utility to millions of couples seeking pregnancy, it has been associated with an increased incidence of premature and very low birth weight births. The fact that fertility assistance therapy has been used primarily by wealthier populations has had the effect of reducing the social disparity in premature and very low birth weight births. 10 Although the scope of this effect has not been fully documented, it appears to be substantial and worthy of more careful analysis.
These recent clinical advances illustrate the power of medical innovations to reshape mechanisms of social influence on health outcomes. Although the forces that drive income inequalities, racial discrimination, and social stratification in American society remain fundamental, the manner in which these forces are ultimately expressed as health outcomes will increasingly be mediated by clinical capabilities, and, therefore, the products of medical research.
The Importance of Tertiary Care and Medical Research to Equity in Outcome
The fastest way to widen social disparities in infant mortality would be to permit social factors to reduce access to advanced perinatal and neonatal care. This is because such care has proven highly effective and has been instrumental in reducing population-based birthweightspecific mortality rates. Therefore, even small differences in access to this effective care can result in large differences in birth weight-specific survival, and consequently, neonatal mortality.
What must be recognized is that access to such advanced perinatal and neonatal care is as important to poor infants as it is to wealthy ones. In fact, as neonatal mortality rates fell over the past two decades, access to high-risk obstetrical services and neonatal intensive care has been the only thing that has kept poor neonates anywhere near their wealthier counterparts in terms of survival. This observation does not diminish the importance of prenatal care or other preventive strategies. It merely accords tertiary obstetrical and pediatric services the respect they deserve and makes the far too rarely made point that access to tertiary services is essential to all children in need, regardless of their social position, and must be protected.
Respect for the impact of tertiary services is particularly important during a period of drastic change in the financial structure of medical services in the United States. Too often, the dramatic reductions in neonatal mortality rates that have occurred over the past quarter century are viewed as somehow being "natural" trends or the product of "better technology." The reality, of course, is that there has been nothing natural about these reductions. In addition, they never could have occurred with better technology alone. It has been the organization of regionalized systems of care and the policies that support their functioning that have been essential in transforming advances in clinical capability into population-based improvements in health outcomes. Except for all those who have worked so hard to create and maintain regionalized systems of care, the tendency has been to take regionalization and its financial supports for granted.
The danger in not recognizing the importance of policies that afford access to tertiary services is that these policies could easily be dismantled. In the face of radical changes in the financing of hospital-based services, we may be witnessing in some areas of the country the "social deregionalization" of perinatal and neonatal intensive care based on the patient's ability to pay. The development of managed care systems has often arranged tight affiliations between hospitals in a particular region. Traditionally, perinatal and neonatal intensive care has been regionalized on the basis of clinical capability. Some of the new managed systems of advanced care, however, appear to be regionalized on the basis of financial affiliation. Without careful attention, clinical regionalization could be replaced by financial regionalization, with potentially harmful effects on perinatal and pediatric outcomes.
Efficacy and Justice: Ending the Battle Between Medical and Social Models
The basic premise of this discussion is that the etiology of social disparities in infant health transcends traditional disciplinary boundaries. Distinctions between prevention and therapy, ambulatory and hospital-based care, and primary and tertiary care, although useful in some analytic settings, can cause as much mischief as insight when singularly invoked to explain disparities in infant health. Indeed, a comprehensive examination of recent perinatal epidemiology even calls into question the more fundamental distinctions between social and biologic etiologies, often framed dichotomously as social and medical models of explanation. 11 By recognizing the impact of medical innovation, of the analytic pivot on efficacy, such distinctions become mostly irrelevant to a conceptual understanding of social disparities in infant health. An illustrative case may be useful. Phenylketonuria is a potentially lethal disorder of complete genetic origin. However, given the extremely effective intervention of dietary modification, virtually all disparities in phenylketonuria outcome today are social in origin. This is because access to the ameliorative diet is largely affected by social factors. This transformation from a completely genetic, or biologic, etiology to an almost completely social mechanism of disparity creation underscores the largely artificial nature of arguments that pit biologic and social etiologies against one another.
Beyond conceptual concerns, disrespect for the importance of medical interventions in disparity creation has important practical ramifications. Devaluing the efficacy of a particular medical intervention inevitably undermines pleas for improved access to it. In this sense, the argument that medical care is irrelevant to social disparities in infant mortality is not a particularly progressive stance, as one is then immediately placed in the position of arguing that access to such medical care is irrelevant. Such a position seems uniquely counterproductive at a time when the struggle to assure access to health care for all Americans needs all the support it can muster.
More useful will be an approach that recognizes that social disparities in child health will not only reflect the growing social inequality of American society but also our collective commitment to provide the fruits of medical innovation to all those in need. Wherever there is a capacity to prevent, modify, or cure conditions that threaten child health, the potential for disparity exacerbation or diminution will exist. Accordingly, a revolution in medical capability necessarily places an expanding burden on delivery systems and public policies to provide such a capability equitably. Embracing social and medical influences within the same analytic purview not only helps bind the fruits of our applied research to the discourse of social policy, it also declares in our epidemiology and our policies that the dual struggles-for efficacy and justice-are, more than ever, inextricably linked.
